Edison - an Investment Research Company - has taken up coverage of the Oncology Venture share
Please visit Edison to read their initiation report: link For further information about Oncology Venture, please contact: Ulla Hald Buhl, COO and Chief IR & or Peter Buhl Jensen, CEOMobile: +45 21 60CommunicationsMobile: +45 2170 89 22E-mail: pbj@oncologyventure.com 1049uhb@oncologyventure.com About Oncology Venture Sweden AB Oncology Venture Sweden AB is engaged in the research and development of anti-cancer drugs via its wholly owned Danish subsidiary Oncology Venture ApS. Oncology Venture has a license to use Drug